ATM S333F
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene ATM
Variant S333F
Impact List missense
Protein Effect loss of function - predicted
Gene Variant Descriptions ATM S333F does not lie within any known functional domains of the Atm protein (UniProt.org). S333F complements survival in response to DNA damage in culture but results in reduced phosphorylation of Atm target proteins Chk2 and H2ax and decreased HDR activity in cultured cells (PMID: 35354106), and therefore, is predicted to lead to a loss of Atm protein function.
Associated Drug Resistance
Category Variants Paths

ATM mutant ATM inact mut ATM S333F

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000051.4
gDNA chr11:g.108247060C>T
cDNA c.998C>T
Protein p.S333F
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_006718843.4 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017789.2 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_005271562.5 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
NM_000051.4 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
NM_000051 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542843.3 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_006718843 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542844.4 chr11:g.108253957C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017790.3 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_047426981.1 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017792 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
NM_001351834.2 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542844 chr11:g.108253957C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_006718843.5 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017791.1 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542840.4 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
NM_000051.3 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542840 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_005271562.6 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017790 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542840.3 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_005271562 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017789 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017792.2 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_047426975.1 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542843.2 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542843 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_047426976.1 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_005271561 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017790.2 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_017017791 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38
XM_011542844.3 chr11:g.108253957C>T c.998C>T p.S333F RefSeq GRCh38/hg38
NM_001351834.1 chr11:g.108247060C>T c.998C>T p.S333F RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
ATM S333F lung small cell carcinoma predicted - sensitive Temozolomide + Veliparib Case Reports/Case Series Actionable In a Phase II trial, Temodar (temozolomide) and Veliparib (ABT-888) combination treatment resulted stable disease in a patient with small cell lung cancer harboring ATM S333F, with a progression-free survival of 4.2 months and an overall survival of 4.2 months (PMID: 29906251; NCT01638546). 29906251